Mechanism of action of and resistance to quinolonesBEARDEN, David T; DANZIGER, Larry H.Pharmacotherapy. 2001, Vol 21, Num 10, pp 224S-232S, issn 0277-0008, 2Article

Intracellular activity of ABT-773 and other antimicrobial agents against Legionella pneumophilaJUNG, Rose; DANZIGER, Larry H; PENDLAND, Susan L et al.Journal of antimicrobial chemotherapy (Print). 2002, Vol 49, Num 5, pp 857-861, issn 0305-7453Article

Integrating fluoroquinolones into the hospital formularyBERTINO, Joseph S.Pharmacotherapy. 2001, Vol 21, Num 10, pp 273S-283S, issn 0277-0008, 2Article

Behind Closed Doors: Medication Storage and Disposal in the HomeWIECZORKIEWICZ, Sarah M; KASSAMALI, Zahra; DANZIGER, Larry H et al.The Annals of pharmacotherapy. 2013, Vol 47, Num 4, pp 482-489, issn 1060-0280, 8 p.Article

Pharmacokinetics and pharmacodynamics of fluoroquinolonesRODVOLD, Keith A; NEUHAUSER, Melinda.Pharmacotherapy. 2001, Vol 21, Num 10, pp 233S-252S, issn 0277-0008, 2Article

Micafungin : A new echinocandin antifungalJOSEPH, Jomy M; JAIN, Rupali; DANZIGER, Larry H et al.Pharmacotherapy. 2007, Vol 27, Num 1, pp 53-67, issn 0277-0008, 15 p.Article

Fluoroquinolone adverse effects and drug interactionsFISH, Douglas N.Pharmacotherapy. 2001, Vol 21, Num 10, pp 253S-272S, issn 0277-0008, 2Article

Tigecycline : A novel broad-spectrum antimicrobialSLOVER, Christine M; RODVOLD, Keith A; DANZIGER, Larry H et al.The Annals of pharmacotherapy. 2007, Vol 41, Num 6, pp 965-972, issn 1060-0280, 8 p.Article

Antimicrobial-coated/bonded and -impregnated intravascular cathetersPAI, Manjunath P; PENDLAND, Susan L; DANZIGER, Larry H et al.The Annals of pharmacotherapy. 2001, Vol 35, Num 10, pp 1255-1263, issn 1060-0280Article

Steady-state plasma and bronchopulmonary characteristics of clarithromycin extended-release tablets in normal healthy adult subjectsGOTFRIED, Mark H; DANZIGER, Larry H; RODVOLD, Keith A et al.Journal of antimicrobial chemotherapy (Print). 2003, Vol 52, Num 3, pp 450-456, issn 0305-7453, 7 p.Article

A prospective and retrospective analysis of the nephrotoxicity and efficacy of lipid-based amphotericin B formulationsCANNON, Joan P; GAREY, Kevin W; DANZIGER, Larry H et al.Pharmacotherapy. 2001, Vol 21, Num 9, pp 1107-1114, issn 0277-0008Article

Steady-state plasma and intrapulmonary concentrations of Levofloxacin and ciprofloxacin in healthy adult subjectsGOTFRIED, Mark H; DANZIGER, Larry H; RODVOLD, Keith A et al.Chest. 2001, Vol 119, Num 4, pp 1114-1122, issn 0012-3692Article

Tissue reparative effects of macrolide antibiotics in chronic inflammatory sinopulmonary diseasesGAREY, Kevin W; ALWANI, Anita; DANZIGER, Larry H et al.Chest. 2003, Vol 123, Num 1, pp 261-265, issn 0012-3692, 5 p.Article

The IS6110 repetitive DNA element of Mycobacterium tuberculosis is not detected in exhaled breath condensate of patients with active pulmonary tuberculosisJAIN, Rupali; SCHRIEVER, Christopher A; DANZIGER, Larry H et al.Respiration (Basel). 2007, Vol 74, Num 3, pp 329-333, issn 0025-7931, 5 p.Article

In vitro bactericidal activities of ABT-773 against ermB strains of Streptococcus pneumoniaeNEUHAUSER, Melinda M; PRAUSE, Jennifer L; DANZIGER, Larry H et al.Antimicrobial agents and chemotherapy. 2003, Vol 47, Num 3, pp 1132-1134, issn 0066-4804, 3 p.Article

Quinupristin-dalfopristin : An overviewDELGADO, George JR; NEUHAUSER, Melinda M; BEARDEN, David T et al.Pharmacotherapy. 2000, Vol 20, Num 12, pp 1469-1485, issn 0277-0008Article

Pharmacodynamic profiling of piperacillin in the presence of tazobactam in patients through the use of population pharmacokinetic models and Monte Carlo simulationLODISE, Thomas P; LOMAESTRO, Ben; RODVOLD, Keith A et al.Antimicrobial agents and chemotherapy. 2004, Vol 48, Num 12, pp 4718-4724, issn 0066-4804, 7 p.Article

Lack of effect of nizatidine-induced elevation of gastric pH on the oral bioavailability of dapsone in healthy volunteersITOKAZU, Gail S; FISCHER, James H; MANITPISITKUL, Prasarn et al.Pharmacotherapy. 2002, Vol 22, Num 11, pp 1420-1425, issn 0277-0008, 6 p.Article

Collection and analysis of exhaled breath condensate in humansMUTLU, Gökhan M; GAREY, Kevin W; ROBBINS, Richard A et al.American journal of respiratory and critical care medicine. 2001, Vol 164, Num 5, pp 731-737, issn 1073-449XArticle

Multi-hospital analysis of antimicrobial usage and resistance trendsLESCH, Christine A; ITOKAZU, Gail S; DANZIGER, Larry H et al.Diagnostic microbiology and infectious disease. 2001, Vol 41, Num 3, pp 149-154, issn 0732-8893Article

Polymyxins: Wisdom Does Not Always Come With AgeKASSAMALI, Zahra; ROTSCHAFER, John C; JONES, Ronald N et al.Clinical infectious diseases. 2013, Vol 57, Num 6, pp 877-883, issn 1058-4838, 7 p.Article

In vitro pharmacodynamic activities of ABT-492, a novel quinolone, compared to those of levofloxacin against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalisGUNDERSON, Shana M; HAYES, Robert A; QUINN, John P et al.Antimicrobial agents and chemotherapy. 2004, Vol 48, Num 1, pp 203-208, issn 0066-4804, 6 p.Article

Markers of inflammation in exhaled breath condensate of young healthy smokersGAREY, Kevin W; NEUHAUSER, Melinda M; ROBBINS, Richard A et al.Chest. 2004, Vol 125, Num 1, pp 22-26, issn 0012-3692, 5 p.Article

Assessing unit dose system discrepanciesMAX, Blake E; ITOKAZU, Gail; DANZIGER, Larry H et al.American journal of health-system pharmacy. 2002, Vol 59, Num 9, pp 856-858, issn 1079-2082Article

Page / 2